DIVISLAB vs SUNPHARMA — stock comparison
Divis Laboratories Ltd (DIVISLAB), Sun Pharmaceutical Industries Ltd (SUNPHARMA): price, valuation, ROE, margins and Traddx's fundamentals grade, side by side. Live NSE/BSE data.
On Traddx's fundamentals score, DIVISLAB grades highest (A 80). Not investment advice.
1-year price performance — higher line = stronger return
■ DIVISLAB +76.8%■ SUNPHARMA +7.8%Past year, rebased to 100
| DIVISLAB | SUNPHARMA | |
|---|---|---|
| Traddx grade | A (80) | B (69) |
| Price | ₹11,472.25 | ₹1,885.15 |
| Today | -0.15% | 0.23% |
| P/E | 88.90 | 36.70 |
| ROE | 16.50% | 16.00% |
| Net margin | 31.26% | 14.19% |
| Debt / equity | 0.00 | 0.04 |
| 52-week high | ₹11,818.00 | ₹2,047.55 |
| 52-week low | ₹5,648.00 | ₹1,583.60 |
Green = the strongest figure on each row (lower is better for P/E and debt; higher for the rest). Grade is Traddx's own fundamentals score.
Open DIVISLAB live → Open SUNPHARMA live →